Concepedia

Eric T. Williams

ET

12

Publications

644

Citations

11

H-Index

2004

Active since

Affiliations

Eli Lilly (United States)(Current)

The University of Texas Health Science Center at Houston

Novartis (United States)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Eric T. Williams is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and natural sciences.

ORCID

Top concepts

Publications per year

2004–2022

12

Publications

12

Characterization of Recombinant Human Carboxylesterases: Fluorescein Diacetate as a Probe Substrate for Human Carboxylesterase 2

Jie Wang, Eric T. Williams, Joanne Bourgea et al. · Drug Metabolism and Disposition · 2011 · 130 citations

The Biotransformation of Prasugrel, a New Thienopyridine Prodrug, by the Human Carboxylesterases 1 and 2

Eric T. Williams, Karen O. Jones, G. Douglas Ponsler et al. · Drug Metabolism and Disposition · 2008 · 127 citations

CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing’s sarcoma

Nathan T. Ross, Felix Lohmann, Seth Carbonneau et al. · Nature Chemical Biology · 2019 · 85 citations · Full text

, , +9

Characterization of the Expression and Activity of Carboxylesterases 1 and 2 from the Beagle Dog, Cynomolgus Monkey, and Human

Eric T. Williams, James A. Bacon, David M. Bender et al. · Drug Metabolism and Disposition · 2011 · 71 citations

A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies

Aparna Hegde, Priyamvada Jayaprakash, Coline A. Couillault et al. · Clinical Cancer Research · 2021 · 58 citations · Full text

Rows per page

1–5 of 12